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Human umbilical vein endothelial cells (HUVECs) dysfunction in
vitro.
METHODS In vivo, obesity-related hypertensive rat models were
induced by high-fat diet for 25 weeks. The aqueous extract of TT and
telmisartan was intragastrically administrated for 8 weeks. Body
weight, blood pressure and heart rate were measured weekly to
observe the slimming beneﬁts and anti-hypertensive effects of the
drugs. The endothelial morphology of the thoracic aorta was observed
by HE staining and scanning electron microscope. The level of serum
lipid was measured by biochemical methods, and serum leptin,
AngII, ET-1, NO, NPY and Hcy was determined by ELISA. In vitro,
HUVECs were pre-incubated for 60 min with TT (30 ug/ml and 3 ug/
ml separately) or 10-5 mol/l telmisartan and then the injured
endothelium model was established by applying 100 mg/ml ox-LDL
for 24 h. Cell viability of HUVECs was observed by real-time cell
electronic sensing assay and apoptosis rate by Annexin V/PI
staining. The cell migration assay was performed with a Trans-
well insert system. Cytoskeleton remodeling was observed by
immunoﬂuorescence assay. The content of eNOS was measured by
ELISA. Intracellular reactive oxygen species (ROS) generation was
assessed by immunoﬂuorescence and ﬂow cytometer. Key genes
associated with the metabolism of ox-LDL were chosen for quanti-
tative real-time PCR to explore the possible mechanism of TT
against oxidized LDL-induced endothelial dysfunction.
RESULTS TT decreased systolic pressure, diastolic pressure, mean
arterial pressure and heart rate, and showed against weight gain ef-
fect. TT improved endothelial integrity of thoracic aorta, decreased
leptin, AngII, ET-1, NPY and Hcy, while increased NO.
In vitro, TT suppressed ox-LDL-induced HUVEC proliferation and
apoptosis rates signiﬁcantly and TT prolonged the HUVEC survival
time and postponed the cell’s decaying stage. TT improved the
endothelial cytoskeletal network and increased cell migration. Addi-
tionally, TT regulated of the synthesis of endothelial nitric oxide
synthase and generation of intracellular reactive oxygen species. TT
signiﬁcantly decreased mRNA expression of PI3Ka and Socs3. It also
increased mRNA expression of Akt1, AMPKa1, JAK2, LepR and STAT3
induced by ox-LDL. The results suggested that the JAK2/STAT3 and/or
PI3K/AKT pathway may be a very important pathway of the pharma-
cological mechanism of TT against endothelium injury.
CONCLUSIONS TT demonstrated excellent slimming beneﬁts, anti-
hypertension and endothelial protective effects. It also suggested that
the JAK2/STAT3 and/or PI3K/AKT pathway might be a very important
pathway which was involved in the pharmacological mechanism of
TT as the vascular protective agent.GW26-e3603
Cardiac Fibroblast Contributes to Myocardial Fibrosis in Mice With
Diabetes Mellitus-Role of Cardiomyocyte-Fibroblast Interaction
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OBJECTIVES The major cardiac cell type expressing HMGB1 is the
cardiac myocyte (CM) while the primary IL-33 expressing cell is
the cardiac ﬁbroblast (CF). Here we delineated the extracellular
communication pathway between cardiomyocyte and ﬁbroblast that
contributes to murine DiCM.
METHODS DM was induced in 6-week-old, male C57BL/6 mice by
intraperitoneal (i.p.) injection of streptozotocin (STZ). The sex
matched littermates were injected with an equal volume of citrate
buffer as controls (pH¼4.5). CMs or CFs cultured individually or in co-
culture were challenged with 30 mM glucose in M199 to simulate the
hyperglycemia of DM. As an osmotic control, the cells were incubated
with 30 mM mannitol in M199. Immunoﬂourescence staining and
Western blot were used for assessment of protein expression of
HMGB1, IL-33 and collagen I and III. A mouse pressure-volume loop
analysis system was used for assessment of myocardial function.
RESULTS 1) myocardial expression of HMGB1 and IL-33 were detected
by immunoﬂourescence staining and Western blot in the murine STZ
model of DM. Myocardial expression of HMGB1 was increased, while
that of IL-33 was decreased at 2 and 4 weeks after achieving a
hyperglycemic state. HMGB1 was primarily localized to the myocytes,
while IL-33 was localized to the interstitial ﬁbroblasts.
2) Mice developed cardiomyopathy six weeks after the induction of
DM as indicated by increased myocardial ﬁbrosis and dysfunction.The myocardial collagen deposition and improvement of myocardial
function were substantially attenuated by inhibition of HMGB1or
exogenous IL-33.
3) Although challenge of isolated CFs with HG increased HMGB1
production, the effects were minimal compared to those noted in CM.
In vitro HG model, cardiac myocytes can potentiate the down-regu-
lation of IL-33 in CFs; an effect mediated by myocyte-derived HMGB1.
4) HG challenge of CFs alone slightly increased collagen I ex-
pression. The effect was signiﬁcantly enhanced when CFs were
co-cultured with CMs; the potentiating effect was abrogated by the
HMGB1 inhibitor, A-box. Further, increase in collagen I expression
by isolated CFs in response to HG, was potentiated by exogenous
administration of HMGB1.
5) When TRL4-/- CFs were co-cultured with wild type CMs, the CM-
induced potentiating effect on down-regulation of CF IL-33 and in-
crease in CF collagen production was negated. Two weeks after the
induction of the STZ model, the expected decrease in IL-33 was
noted in WT mice, but ,it was not evident in TLR4-/- mice. Further， in
TLR4-/- mice, the STZ-induced myocardial ﬁbrosis and dysfunction
were blunted.
CONCLUSIONS Our data support that cardiac myocyte-ﬁbroblast
interaction plays a key role in diabetic myocardial ﬁbrosis. Specif-
ically, our study indicates myocyte HMGB1-ﬁbroblast TLR4/IL-33 axis
contributes to the development of myocardial ﬁbrosis and dysfunc-
tion in mice with diabetes.
The study was supported by a grant from the National Natural
Science Foundation of China (grant number: 81370333)
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Postinfarction Gene Therapy With Hepatocyte Growth Factor Mitigates
Cardiac Remodeling and Dysfunction
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OBJECTIVES To investigated beneﬁcial effects and its mechanisms of
naked plasmid expressing recombinant human hepatocyte growth
factor on left ventricular remodeling and dysfunction.
METHODS Acute myocardial infarction was induced male SD rats by
ligating anterior descending of left coronary artery. These rats were
randomly assigned to HGF group (n¼8); a single myocardial injection
of naked plasmid expressing HGF (250 ug/injection) immediately after
left coronary artery ligation. Control group (n¼8);myocardial injection
of same dose naked plasmid without HGF, normal group (n¼10); the
suture was passed but not tied treated. After four or eight weeks.
cardiac function was evaluated by echocardiography respectively, the
cardiacs specimens at eight-week time point were subjected to Mas-
son staining and immunohistochemical analysis.
RESULTS Four weeks later, left ventricular remodeling and dysfunc-
tion were apparent,and LV anterior wall thickness (LVAWT) were
signiﬁcantly reduced (P<0.001) in the control group. However, left
ventricular remodeling and dysfunction were signiﬁcantly relieved
(p<0.05) and LVAWT were thicker (p¼0.378) in the HGF group.
Eight weeks later, HGF-treated rats showed that left ventricular
remodeling and dysfunction were still signiﬁcantly improved
(p<0.05), furthermore ,signiﬁcant mitigation of LVAWT was seen in
HGF-treated rats (P<0.05). Eight weeks later, the infarct size signiﬁ-
cantly reduced and the infarct wall was thicker in the HGF-treated
rates (P<0.05). Myocardial ﬁbrosis was signiﬁcantly reduced and the
density of blood capillary was signiﬁcantly increased in the myocar-
dial infarcted area in HGF group (P<0.001)
CONCLUSIONS Recombinant human hepatocyte growth factor im-
proves postinfarction cardiac remodeling and dysfunction by
reducing infarct size and myocardial ﬁbrosis and increasing by density
of blood capillary.
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OBJECTIVES Diabetes is an independent risk factor of heart failure
and mortality after myocardial infarction(MI). The activity and
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(SERCA2a) decrease in diabetes, leading to diastolic and systolic
dysfunction of myocardium. It was recently reported that SUMOyla-
tion could elevate the activity and stability of SERCA2a. We assume
that diabetes might affect the intensity of SUMOylation of SERCA2a
after MI.
METHODS Diet-induced type 2 diabetic rats and controls were divided
into suture ligation induced MI groups or sham groups. Primary car-
diomyocytes were cultured in different concentrations of glucose and
insulin, and underwent oxygen deprivation(OD) for 6 or 12 hours.
Echocardiograph and left ventricular pressure were measured to
determine cardiac function. The intensity of SUMOylation of SER-
CA2a, expressions of SERCA2a, SUMO1 and enzymes of SUMOylation
were evaluated.
RESULTS Diabetes exacerbated diastolic and systolic dysfunction of
myocardium after infarction. SUMOylation intensity of SERCA2a
was enhanced in 1-week-post-MI non-diabetic rats and 6-hour-OD
cardiomyocytes but not in 4-week-post-MI rats and 12-hour-OD
cardiomyocytes. The expression of enzyme 2 of SUMOylation,
namely Ubc9, was in accordance with the SUMOylation intensity,
while SUMO1 and enzyme 1 were not changed. This compensatory
enhancement was almost completely blunted in 1 or 4 weeks
post-MI diabetic rats. Interestingly, glucose alone increased Ubc9
expression and the SUMOylation intensity of SERCA2a of car-
diomyocytes in vitro in a concentration-dependent manner; how-
ever, with addition of insulin, glucose decreased Ubc9 and
SUMOylation intensity in a concentration-dependent manner on the
contrary, while SUMO1 and enzyme 1 were also not changed.
Additionally, overexpression of Ubc9 with lentivirus neutralized the
decreasing of SUMOylation intensity caused by glucose and insulin
in vitro.
CONCLUSIONS SUMOylation intensity of SERCA2a was compensa-
tory enhanced in post-MI non-diabetic rats, but not in diabetic rats.
SUMOylation intensity of SERCA2a decreased in cardiomyocytes
with addition of high glucose and insulin in vitro, which could be
neutralized by overexpression of Ubc9. These observations provide
evidence that Ubc9 and SUMOylation of SERCA2a is involved
in diabetes-mediated exacerbation of left ventricular dysfunction
after MI.
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DCPIB Attenuates Myocardial Ischemia/Reperfusion Injury Through
Inhibiting Autophagy in Rat Model
Yuesheng Xia, Lin Wang, Rong Xu, Yuan Xiao, Xiaoming Wang
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OBJECTIVES Autophagy plays a contradictory role in myocardial
ischemia/reperfusion (I/R) process, which acts as both beneﬁcial
cardioprotective during ischemia stress and myocardial injury
in response to subsequent reperfusion. DCPIB (4-[(2-Butyl-6,7-
dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] buta-
noic acid), a selective inhibitor of volume-sensitive outwardly
rectifying (VSOR) chlorine channel, has been determined to pro-
tect cardiomyocytes from reperfusion damage. However, the un-
derlying mechanism remains unclear. The present study explored
the possible mechanism of DCPIB in alleviating myocardial I/R
injury.
METHODS Sprague-Dawley rats were randomly divided into sham
operation group, I/R group, I/R+Rapamycin (RAPA) group, I/R+DCPIB
group, I/R+3-methyladenine (3MA, a autophagic inhibitor) group and
I/R+RAPA+DCPIB group, with 6 rats in each group. Rats were per-
formed to ischemia 30 minutes and subsequent reperfusion 24 hours,
DCPIB (10mg/kg), RAPA(4mg/kg) and 3MA (1mg/kg) were adminis-
tered as intraperitoneal injection 10 min before the onset of reperfu-
sion, respectively. Serum myocardial enzymes were measured and
light microscopic study was performed, the myocardial LC3 was
detected by immunohistochemistry, nuclear factor-kB (NF-kB) and
tumor necrosis factor a (TNF-a) were detected by enzyme-linked
immunosorbent assay (ELISA).
RESULTS The expressions of myocardial LC3, TNFa and NF-kB
were signiﬁcantly increased (P<0.05), and cardiac function was
declined in I/R group compared with that in sham operation
group (P<0.05), myocardial LC3 were furthermore increased in
RAPA group, whereas these could be reversed through 3MA, a
autophagic inhibitor. Of note, DCPIB administration caused sig-
niﬁcant reduction of myocardial LC3, TNF-a and NF-kB (P<0.05),and signiﬁcantly improved the cardiac functional recovery and
reduced myocardial enzymes activity compared with that in I/R
group and I/R+RAPA+DCPIB group (P<0.05). Speciﬁc details for
hemodynamics, compared to sham-operated group, left ventricular
systolic pressure (LVSP), maximal rate of increase of ventricular
pressure (+dp/dtmax) and maximal rate of decrease of ventricular
pressure (-dp/dtmax) decreased while left ventricular end diastolic
pressure (LVEDP) signiﬁcantly increased markedly in I/R group
and I/R+RAPA group (P<0.05), however, DCPIB indeed reversed
the disorder.
CONCLUSIONS Our results demonstrated that DCPIB attenuated
excessive autophagy to protect rat heart from I/R injury.GW26-e3941
Urokinase Receptor Accelerates Ox-LDL Uptake and Foam Cell Formation
by Upregulating CD36 Expression on Macrophages
Yan Zhang, Wei Chen, Quan Fang
Peking Union Medical College Hospital
OBJECTIVES To investigate the role of uPAR in ox-LDL uptake and
the interaction of uPAR and CD36 in ox-LDL internalization by
macrophages.
METHODS THP-1 cells transfected with uPAR complementary DNA
(uPAR overexpression THP-1, UOT) or with uPAR shRNA (uPAR low-
expression THP-1, ULT) were established. Laser Scanning Confocal
Microscope and dil-ox-LDL were used to evaluate ox-LDL uptake
capacities. Oil red O staining was performed to measure lipid accu-
mulation and foam cell formation. Cytokine expression levels of
cytokines were quantitated by Real-Time-PCR.
RESULTS Ox-LDL-induced uPAR expression was independent of its
baseline expression level in macrophages. UOT cells showed a strong
correlation of uPAR expression with ox-LDL uptake. Much earlier dil-
ox-LDL internalization and signiﬁcantly more lipid droplets were
found in UOT cells. Stable expression of a shRNA targeting uPAR gene
strongly inhibits lipid uptake by macrophages. UOT cells exhibited
signiﬁcantly higher transcriptional levels of CD36 mRNA upon stim-
ulation of ox-LDL.
CONCLUSIONS uPAR accelerates ox-LDL uptake and foam cell
formation in macrophages, which may be mediated by CD36 up-
regulation. The interaction between uPAR and CD36 may be a
potential new therapeutic target.
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Activation of D4 Dopamine Receptor Decreases AT1 Angiotensin II
Receptor Expression in Rat Renal Proximal Tubule Cells
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OBJECTIVES The dopaminergic and renin angiotensin systems
interact to regulate blood pressure. Disruption of the D4 dopamine
receptor gene in mice produces hypertension that is associated with
increased renal AT1 receptor expression. We hypothesize that D4 re-
ceptor can inhibit AT1 receptor expression and function in renal
proximal tubules (RPTs) cells from Wistar-Kyoto (WKY) rats, the
regulation of D4 receptor on AT1 receptor is aberrant in RPT cells from
spontaneously hypertensive rats (SHRs).
METHODS The AT1 receptor protein expression is detected by
immunoblotting. Na+-K+-ATPase activity was determined as the rate
of inorganic phosphate released in the presence or absence of
ouabain.
RESULTS The D4 receptor agonist, PD168077, decreased AT1 receptor
protein expression in a time (0-30hrs)- and concentration (10-9-10-5M)-
dependent manner in WKY RPT cells. In contrast, in SHR cells,
PD168077 (10-6M) increased AT1 receptor protein expression. The
inhibitory effect of D4 receptor on AT1 receptor expression in WKY
RPT cells was blocked by a calcium channel blocker, nicardipine
(10-6M) or calcium free medium, indicating that calcium channel was
involved as a signaling molecule in the D4 receptor-mediated
signaling pathway. Angiotensin II (10-11M) increased Na+-K+ ATPase
activity in WKY cells. Pretreatment with PD168077 (10-6M/24hrs)
decreased the stimulatory effects of angiotensin II on Na+-K+ ATPase
activity in WKY cells. However, in SHR cells, the inhibitory effect of D4
receptor on angiotensin II-mediated effect on Na+-K+ ATPase activity
